Gastrointestinal Cancer News

March is Colorectal Cancer Awareness Month.

In a research collaboration with Mayo Clinic, nanomedical company NaNotics LLC plans to develop and assess a novel subtractive nanoparticle for use in cancer treatment.

In a Healio video exclusive, Gerard Mullin, MD, associate professor of gastroenterology and hepatology at Johns Hopkins University, told Healio that taller adults may have an increased risk for colorectal cancer.

Black Medicare beneficiaries who underwent elective cancer surgery had higher rates of mortality than their white counterparts, irrespective of neighborhood deprivation or dual eligibility status, according to study results.

Medical device company Medtronic and the ASGE have collaborated to create the Medtronic Health Equity Assistance Program, which aims to improve access to colorectal cancer screening technologies in underserved U.S. communities.

Daily electronic patient-reported outcome assessments may provide valuable insight into symptom management among patients with cancer undergoing antineoplastic treatment, according to a study published in JAMA Network Open.

In patients with inflammatory bowel disease, colonoscopy within 3 years before colorectal cancer diagnosis was linked with early tumor stage detection, while colonoscopy within 1 year reduced overall all-cause mortality, according to data.

In a press room briefing, President Joseph R. Biden Jr. proclaimed March 2022 to be National Colorectal Cancer Awareness Month and announced the creation of the Advanced Research Projects Agency for Health.

A phase 3 study of acelarin in combination with cisplatin for biliary tract cancer is being discontinued at the recommendation of the study’s independent data monitoring committee, according to a press release from the agent’s manufacturer.

Pathogenic variants in BRCA1 and BRCA2 appeared associated with increased risks for prostate cancer, pancreatic cancer, male breast cancer and possibly stomach cancer, according to research published in Journal of Clinical Oncology.